Genetic Counseling (Lecture 7)

Career Path and Role of Genetic Counselors

  • Genetic counselor: an individual with specialized training in medical genetics who helps people understand and adapt to the medical, psychological, and familial implications of genetic disease or genetic disorders.
  • Training pathway: typically a 2-year2\text{-year} master’s program; common undergrad backgrounds are biology or molecular biology; some come from counseling backgrounds because genetic counseling intersects biology/genetics with psychosocial counseling.
  • Core purpose: blend biology/genetics with counseling to support patients and families, often in clinic settings; involve both patient and family members.

Personal Journey into Genetic Counseling

  • Speaker’s background: from the St. Louis area; attended Westeros High School; loved biology and genetics but not bench lab work; pursued genetics as a career because it aligns with people-facing interests and scientific passion.
  • Early exploration: took a senior-year genetics course; a brief mention of careers in genetics led to discovering genetic counseling.
  • Undergraduate shadowing: studied at the University of Missouri in Columbia; reached out to local genetic counselors (cold calling) and shadowed extensively.
  • Grad school path: at the time, ~2323 programs offered genetic counseling; chose Arcadia University (a small private school near Philadelphia) for the master’s program; Arcadia is now housed within the University of Pennsylvania.
  • Graduation timeline: completed the master’s program in 2002/20052002/2005 (program completed in 2002 or 2005 depending on record; transcript cites 02/2005).
  • Early career focus: first job as a clinical genetic counselor; initial exposure centered on the clinical side of genetics.

Early Career: Traditional Clinical Areas in Genetic Counseling

  • Pediatric genetic counseling: works in a pediatric genetic department with a medical geneticist; referrals include congenital anomalies, immunodeficiency, developmental delay, autism, and other pediatric concerns.
  • Cancer genetic counseling: focuses on hereditary cancer syndromes (e.g., BRCA-related breast/ovarian cancer); involves both pediatric and adult sides for hereditary cancer scenarios.
  • Prenatal genetic counseling: supports families during pregnancy or preconception; discusses potential genetic conditions in the family or fetus; addressed cases with ultrasound findings or abnormal screening.
  • Traditional scope: these three areas were the core traditional fields of genetic counseling when the speaker started.
  • Field growth: genetics is an ever-expanding field; opportunities expanded beyond clinic into laboratory work, sales, education, and research.

Transition to Laboratory Genetic Counseling and New Testing Frontiers

  • Shift in career: after ~10 years10\text{ years} in prenatal/high-risk perinatal clinic work, speaker moved into a laboratory role at Washington University focusing on next-generation sequencing (NGS).
  • New job focus: lab-based genetic counseling for cancer testing and disease-focused inherited testing (e.g., cardiac or renal diseases); less direct patient contact, more telephone-based patient communication.
  • Key realization: combining genetics with lab science and education, expanding the role of genetic counselors beyond direct patient care.
  • Current tenure: speaker has been at WashU for 11 years11\text{ years} in the lab setting.

What the Laboratory Does: Testing Platforms and Scope

  • Three main testing areas offered by the lab:
    • Disease-focused gene panels (e.g., cardiac panels for cardiomyopathy or arrhythmias; renal panels for end-stage renal disease or polycystic kidney disease; panels for genetic forms of diabetes).
    • Whole exome sequencing (WES) and whole genome sequencing (WGS): broader testing; WES targets coding regions; WGS covers the entire genome.
    • Somatic mosaicism panels: test somatic variants confined to affected tissue (non-germline), such as overgrowth disorders or vascular anomalies; tissue from the affected area is tested to identify driver variants.
  • Rapid genome sequencing: a specialized service for NICU babies or pediatric ICU patients with congenital anomalies; preliminary results in 2 to 3 days2\text{ to }3\text{ days} to guide treatment.
  • Definitions to know:
    • Gene panels: test a subset of genes associated with a particular condition.
    • Exome sequencing: analyzes the coding portions of DNA (the exome).
    • Genome sequencing: analyzes the entire DNA sequence.
    • Somatic variants: genetic changes that arise after conception and may be present only in a tissue or region of the body.
  • Daily activities related to testing: clinicians call with questions about test options, ordering, specimen requirements, turnaround times, and billing.

The Testing Landscape: Panels, WES/WGS, and Practical Considerations

  • Testing options and rationale:
    • Panels are limited to specific genes linked to a disease, enabling targeted analysis.
    • WES provides broader data by sequencing coding regions; WGS provides the most comprehensive data.
    • Rapid genome sequencing is especially valuable in critical neonatal/pediatric settings to inform urgent care decisions.
  • Somatic mosaicism testing: focuses on somatic variants that may drive localized tissue disorders rather than inherited conditions.
  • Common clinical questions involve choosing the appropriate test, specimen type, turnaround times, and billing considerations.
  • Insurance and coverage is a major practical hurdle:
    • Genetic testing is widely available, but insurance coverage varies considerably between plans.
    • Example dynamics: some insurers deny large multi-gene panels automatically; others require medical record review to determine medical necessity.
    • Evicor (owned by Cigna) is a contract partner to many plans and employs a team of over 50 genetic counselors50\text{ genetic counselors} who review precertifications, pull records, and communicate determinations; they may approve testing if certain conditions are met and provide rationale when denial occurs.
    • This insurance liaison role aligns with nontraditional genetic counseling work, bridging clinicians, patients, and payers.

Licensure, Regulation, and National Practice Landscape

  • Licensure status: in the US, 3535 states license genetic counselors; Missouri is not currently licensed.
  • Importance of licensure and Medicare recognition: to order testing and bill appropriately, genetic counselors need to be Medicare-recognized providers; CMS (Centers for Medicare & Medicaid Services) governs provider recognition across the US.
  • Ongoing efforts: aim to achieve licensure in all 50 states to enable genetic counselors to order tests and be reimbursed as recognized providers; there are currently 15 states without licensure.
  • Regulatory oversight: labs in the US performing clinical testing must be accredited by CMS and CAP; labs are inspected every two years; the speaker’s lab is in an inspection window and conducts both external inspections and internal self-inspections in off years.
  • What inspections cover: a wide range of policies—from test ordering and specimen labeling to data interpretation, privacy, and storage.
  • Role of SOPs: during inspection periods, extensive review and updating of standard operating procedures (SOPs) and possibly creation of new policies to comply with new regulations.
  • In addition to regulatory responsibilities, the lab maintains ongoing quality assurance and prepares for both external inspections and internal audits.

Education, Teaching, and Role in Training the Next Generation

  • Teaching responsibilities: the speaker teaches a course on laboratory genetic counseling to the master’s program students at Washington University; the course is part of the first-semester curriculum for first-year students.
  • Fellowship programs: WashU houses two fellowship tracks within the Department of Pathology that interact with the genetics lab:
    • Molecular Genetic Pathology fellowship (MGP)
    • Laboratory Genetics and Genomics (LGG) fellowship
    • Fellows rotate through the speaker’s lab as well as other labs in the department and engage in clinical genetics work.
  • On-service training: there is a dedicated on-service person each month who reviews cases from the sequencer, interprets variants, and teaches fellows how to review variants and draft reports.
  • Variant interpretation training: the speaker explains variant classification using criteria from the American College of Medical Genetics and Genomics (ACMG): benign, pathogenic, and variants of uncertain significance (VUS); there are also criteria distinguishing somatic vs. germline variants.
  • Variant interpretation workflow:
    • Evaluate sequencing data with a specialized program to identify variants.
    • Classify variants based on population frequency (common variants are likely benign; rare or absent variants may be pathogenic).
    • When a variant is a VUS, consider clinical context, additional testing (e.g., extending to WES if only a panel was negative), and potential functional studies.
    • Reanalysis over time: a variant initially labeled as VUS may be reclassified later as new data are published.
    • If a pathogenic variant is found, testing activities may stop for that patient or proceed with confirmation and family testing considerations.
  • Education also includes training on drafting clinical reports and interpretations for variants, ensuring clear communication to ordering clinicians.

Clinical Communication, Patient Interaction, and Case Management

  • Direct patient interaction: patients may call with questions about specimen collection or testing, but genetic testing generally must be ordered by a provider (physician, nurse practitioner, etc.).
  • Provider-focused calls: the majority of calls come from clinicians, office staff, or technologists rather than patients directly.
  • Patient-facing considerations: clinicians and patients may seek guidance on testing options, test ordering, sequencing results, and interpretation in the context of specific phenotypes or family history.
  • Practical example regarding test authorization: patient scenarios include prenatal cases, ovarian cancer with BRCA considerations, and other cancer-related testing where insurance criteria may require modification of the test (e.g., smaller panel) or use of grants for coverage when denial occurs.

Ethical, Philosophical, and Real-World Implications

  • Access and equity: licensure and Medicare recognition influence who can order testing and obtain reimbursement, affecting patient access to testing.
  • Insurance navigation as a core responsibility: genetic counselors increasingly work with insurers to explain medical necessity and propose alternative testing strategies when coverage is limited.
  • Data interpretation and uncertainty: VUS results illustrate the ethical challenge of communicating uncertainty to patients and families while pursuing additional data and reanalysis over time.
  • Privacy, policy, and regulation: frequent updates to SOPs and compliance with privacy laws reflect the ongoing ethical obligation to protect patient information.
  • The evolving role of genetic counselors: expansion into laboratory, insurance, education, research, and sales demonstrates the field’s versatility and the need for continuous professional development.

Key Takeaways and Connections to Foundational Principles

  • Genetics is rapidly expanding beyond traditional clinics into laboratories, industry, and education, increasing demand for trained genetic counselors.
  • Core skills include genetic knowledge, counseling fundamentals, clinical interpretation, and an understanding of insurance and regulatory landscapes.
  • Practical workflow from patient referral to test reporting includes specimen handling, variant interpretation using ACMG criteria, report drafting, and communication with clinicians.
  • Ethical considerations center on patient access to testing, informed consent, communicating uncertainty (VUS), data privacy, and equitable reimbursement.
  • The field relies on interdisciplinary collaboration among clinicians, laboratorians, payers, and educators to optimize patient care and advance precision medicine.

Notable Data Points and References (with LaTeX formatting)

  • Training: 2-year2\text{-year} master’s program in genetic counseling.
  • Programs in the past: approximately 2323 programs offering genetic counseling.
  • Career duration in clinical space before switching to lab: 10 years10\text{ years}.
  • Years in current lab role: 11 years11\text{ years}.
  • Rapid genome sequencing turnaround: 2 to 3 days2\text{ to }3\text{ days} for preliminary results.
  • States with genetic counselor licensure: 3535 states (as of the time of speaking).
  • Licensure gap: 1515 states without licensure yet.
  • Team size for precertification review: >5050 genetic counselors on Evicor’s team.
  • Fellowships at the speaker’s institution: 22 fellowship tracks (MGP and LGG).

Final Practical Notes for Exam Preparation

  • Remember the three traditional clinical areas and how they differ: pediatric, prenatal, and hereditary cancer counseling.
  • Understand the expansion into laboratory genetic counseling and the typical day-to-day activities in a genetic testing lab (client liaison, education, regulation, and testing operations).
  • Be able to explain the differences between gene panels, WES, and WGS, including when each is used and what information they provide.
  • Know what rapid genome sequencing is and why it’s used in NICU/pediatric settings.
  • Be able to describe somatic mosaicism testing and how it relies on tissue-specific sampling.
  • Be prepared to discuss how variant interpretation works, including the ACMG criteria and the concept of VUS, using population frequency and phenotypic context.
  • Understand practical insurance challenges and strategies (panel sizing, grants, and precertification processes) and the role of industry partners like Evicor.
  • Recognize the regulatory framework (CMS/CAP accreditation, periodic inspections, SOP updates) and why licensure across states and Medicare recognition matter for practice.
  • Acknowledge the educational mission of teaching genetic counseling and training the next generation of clinicians and laboratory professionals.

Post-Transcript Reflections

  • The speaker emphasizes the value of a flexible career path within genetics, showing how foundational knowledge can adapt to both patient-facing and laboratory roles.
  • The evolving regulatory and insurance landscape underscores the importance of advocacy and policy work in enabling access to genomic medicine.
  • The integration of education, regulation, and practical testing workflows highlights how a single profession can influence multiple facets of healthcare delivery.